loading page

Selecting endogenous promoters for improving biosynthesis of squalene in Schizochytrium sp.
  • +4
  • Fang-Tong Nong,
  • Zi-Xu Zhang,
  • Lu-Wei Xu,
  • Fei Du,
  • Wang Ma,
  • Xiaoman Sun,
  • Guang Yang
Fang-Tong Nong
Nanjing Normal University
Author Profile
Zi-Xu Zhang
Nanjing Normal University
Author Profile
Lu-Wei Xu
Nanjing Normal University
Author Profile
Fei Du
Nanjing Normal University
Author Profile
Wang Ma
Nanjing Normal University
Author Profile
Xiaoman Sun
Nanjing Normal University

Corresponding Author:xiaomansun@njnu.edu.cn

Author Profile
Guang Yang
Nanjing Normal University
Author Profile

Abstract

Squalene (C30H50) is an acyclic triterpenoid compound renowned for its myriad physiological functions, such as anticancer and antioxidative properties, rendering it invaluable in both the food and pharmaceutical sectors. Owing to the constraints on natural resources, microbial fermentation has emerged as a prominent trend. Schizochytrium sp. known to harbor the intact Mevalonate (MVA) pathway, possesses the inherent capability to biosynthesize squalene. However, there is a dearth of reported key genes in both the MVA pathway and the squalene synthesis pathway, along with the associated promoter elements for their modification. This study commenced by cloning and characterizing 13 endogenous promoters derived from transcriptome sequencing data. Subsequently, five promoters exhibiting varying expression intensities were chosen from the aforementioned pool to facilitate the overexpression of the squalene synthase gene SQS, pivotal in the MVA pathway. Ultimately, a transformed strain designated as SQS-3626, exhibiting squalene production 2.8 times greater than that of the wild-type strain, was identified. Lastly, the optimization of nitrogen source concentrations and trace element contents in the fermentation medium was conducted. Following 120 hours of fed-batch fermentation, the accumulated final squalene yield in the transformed strain SQS-3626 reached 2.2 g/L.
11 Apr 2024Submitted to Biotechnology Journal
12 Apr 2024Reviewer(s) Assigned
21 Apr 2024Review(s) Completed, Editorial Evaluation Pending
23 Jul 20241st Revision Received
27 Jul 2024Assigned to Editor
27 Jul 2024Submission Checks Completed
27 Jul 2024Review(s) Completed, Editorial Evaluation Pending
27 Jul 2024Reviewer(s) Assigned
14 Aug 2024Editorial Decision: Accept